← SynDRA

ENTECAVIR ANHYDROUS

SynDRA canonical compound SYN0001538 — structure-anchored drug synonym record

All known targets

• HBV RT
• HBcAg
• P

Mechanisms of action (all sources)

• DNA replication inhibitor
• nucleoside reverse transcriptase inhibitor
• HBV RT MODULATOR
• P inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• ACHE
• ADORA1
• TBXA2R
• SLC6A4
• SLC6A3
• SLC6A2
• PTGS1
• PGR
• PDE4A
• PDE3A
• OPRM1
• MAOA
• KCNH2
• HTR2B
• HTR1A
• HRH3
• F2
• ESR1
• DRD3
• DRD1
• CHRM2
• CHRM1
• AR
• ADRA2A
• ADRA1A
• TDP1

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

• KSYK
• SYK

Drug classes

• Anti-Infective Agents
• Antiviral Agents

ATC classes

• J05A · DIRECT ACTING ANTIVIRALS

Cross-references

• PubChem CID: 135398508
• ChEMBL: CHEMBL713
• DrugBank: DB00442
• ChEBI: CHEBI:473990
• KEGG: D04008
• RxNorm: 1546027
• Wikipedia: Entecavir
• TTD: D0KR2J
• LINCS BRD: BRD-K08206212

Synonyms

• BARACLUDE
• Baraclude
• ENTECAVIR
• entecavir
• entecavir monohydrate
• anhydrous entecavir
• BMS-200475-01
• baraclude
• entecavir hydrate
• Anhydrous entecavir
• Entecavir
• ETV
• Entecavir hydrate
• Entecavir monohydrate
• BMS-200475
• Baraclude (TN)
• Entecavir (INN)
• Entecavir (USAN)
• Entecavir hydrate (JAN)
• SQ-34676
• Entecavir Hydrate
• entecavir (usp monograph)
• NNU2O4609D
• entecavir monohydrate (ep monograph)
• SQ34676
• BMS 200475-01
• entecavir monohydrate (usp-rs)
• entecavir (anhydrous)
• CHEBI:473990
• DTXCID2026446
• Entecavirum
• RefChem:5792
• J05AF10
• BMS20047501
• BMS-20047501
• MFCD00907887
• Entecavir [USAN:INN]
• Entecavir [INN]

Reported adverse events

• Lactic acidosis
• Alopecia
• Anaphylactoid reaction
• Hepatitis
• Dizziness
• Dyspepsia
• Fatigue
• Glycosuria
• Headache
• Insomnia
• Nausea
• Somnolence